Podcast CME Course Information

Exam: Exam 445: The World Health Organization's Essential Diagnostics List: Diagnostics for neurologic disorders

Issue: October 08, 2019

Learning Objectives

The World Health Organization's Essential Diagnostics List: Diagnostics for neurologic disorders

Upon completion of this podcast, participants will be able to discuss the Essential Medicine List (EML), the Essential Diagnostics List (EDL), and understand the importance of attaining accurate representation of neurologic disease on these lists.

Recommended Audience

This program is designed for physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine.

Core Competencies

  • Patient Care
  • Medical Knowledge


Program Accreditations Subcommittee (PAS) is responsible for reviewing and evaluating all CME programs. Joseph F. Kass, MD, JD, FAAN, has received personal compensation for activities as an expert witness in litigation and in an editorial capacity for the American Academy of Neurology. Barney J. Stern, MD, FAAN, has received personal compensation for book chapter contributions. The other members of the committee (Samir Belagaje, MD; J. Clay Goodman, MD, FAAN; Omotola A. Hope, MD; Shannon M. Kilgore, MD, FAAN) and AAN staff (Kristine Mitchell) report no disclosures. Robert A. Gross, MD, PhD, FAAN, has received funding for travel and/or speaker honoraria from the American Academy of Neurology; receives a stipend as Editor-in-Chief of Neurology; has received consultant fees from GlaxoSmithKline and Harris Interactive; has served on speakers' bureaus for Abbott, UCB, and GlaxoSmithKline; has conducted clinical trials over the past 5 years funded by GlaxoSmithKline, UCB, Ortho-McNeil, Pfizer, and Marinus, but has ceased participation in industry-sponsored clinical trials and speakers' bureaus since his appointment as Neurology EIC in 2010; and has received research support from the Department of the Army, UCBPharma, and University of Rochester Medical Center/NIH. Dr. Stacey Clardy serves as Podcast Editor for Neurology® and has received research support forWestern Institute for Biomedical Research (WIBR). Dr. Jeff Ratliff serves as Podcast Deputy Editor for Neurology andreceived a speaker honorarium from Haverford College. AAN staff members editing the test (P Baskin, L Kleffman, K Aman Ramm) have no disclosures. The CME Journal Editors who have reviewed the exam are James WM Owens Jr., MD PhD, who receives royalties from UpToDate, Waltham, MA; grant support from NIH (PI, K08NS054882); and a stipend in his editorial capacity for Neurology and Adam Kelly, MD, who has served as Guest Editor of Continuum (April 2014) and receives a stipend in his editorial capacity for Neurology.

Dr. Gregory Day has served on the editorial boards for DynaMed and EBSCO; has received commercial research support from Avid Pharmaceuticals, Eli Lilly, Roche, and Biogen; has received academic research support from the Barnes Jewish Hospital Foundation and the Chan Zuckerberg Foundation; has received foundation/society research support from the American Brain Foundation and Eugene M Johnson Jr. Weston Brain Institute; holds stock options in ANI Pharmaceuticals; and has acted as a consultant in legal proceedings for Hendrick Medical Center. Dr. Kiran Thakur has served as a consultant for the World Health Organization and has received governmental research support from NICHD/NIH and NINDS. Dr. Stacey Clardy has received research support from Western Institute for Biomedical Research (WIBR); and serves as the Section Editor of the Neurology Podcast. Dr. Sean Pittock has served on the scientific advisory board for Alexion Pharmaceutical, Medimmune/Viele Bio, and UCB pharmaceuticals; holds patents for neuromyelitis optica autoantibodies as a marker for neoplasia, for a method for treating NMO administration of Eculizumab to an individual that is aquaporin-4 (AQP4)-IgG autoantibody positive, and has a patent pending for GFAP, Septin-5 and MAP1B autoantibodies as biomarkers of neurological autoimmunity; has served as a consultant for Alexion Pharamaceuticals and Medimmune—Dr. Pittock has not received compensation through these organizations for these consultancies; is employed by the Mayo Clinic; and has received commercial research support from Grifols, Medimmune, Alexion, and Autoimmune Encephalitis Associations.

CME Expiration

CME expires three years after publication date or sooner if podcasts are deemed out of date by reviewers.


The American Academy of Neurology Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA PRA Credit™

The American Academy of Neurology Institute designates this journal-based-CME activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


The American Academy of Neurology holds copyright for all materials in this exam.


Any information regarding the identity of individuals taking the exam or their exam scores will be kept confidential.

Hardware and Software Requirements

A computer with a web browser such as Internet Explorer, Firefox, Safari, or Google Chrome is required.

Start this exam

For More Information

Patty Baskin

Executive Editor, Neurology®
(612) 928-6021